State-of-the-art: prostate LDR brachytherapy.
This article on low dose rate (LDR) prostate brachytherapy reviews long-term results, patient selection and quality of life issues. Mature results from the United States and United Kingdom are reported and issues regarding definitions of biochemical failure are discussed. Latest data comparing brachytherapy with radical prostatectomy or no definitive treatment and also the risk of secondary malignancies after prostate brachytherapy are presented. Urological parameters of patient selection and quality of life issues concerning urinary, sexual and bowel function are reviewed. The position of prostate brachytherapy next to surgery as a first-line treatment modality is demonstrated.
Voulgaris
S
S
Department of Urology, St Luke's Cancer Centre, Royal Surrey County Hospital, Guildford, Surrey, UK. bstelios@doctor.com
Nobes
J P
JP
Laing
R W
RW
Langley
S E M
SE
D001918:Brachytherapy / Q000379:methods*; D019583:Dose Fractionation, Radiation; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008954:Models, Biological; D018579:Patient Selection; D011468:Prostatectomy / Q000379:methods; D011471:Prostatic Neoplasms / Q000532:radiotherapy*; D011788:Quality of Life; D011879:Radiotherapy Dosage